Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma.

Genetic alterations that lead to loss or changes in tumour-suppressor genes are known to contribute to oral carcinogenesis. Traditional molecular methods to detect such losses have relied on mutation analysis or deletion of the gene. However, epigenetic mechanisms could also contribute to silencing of tumour-suppressor genes. Methylation regions rich in CpG promoters prevent DNA transcription by changing the binding of histone complexes. The substantial contribution of methylation, specifically in oral squamous-cell carcinoma, is now being realised and investigated.

[1]  A. Read,et al.  DNA studies underestimate the major role of CDKN2A inactivation in oral and oropharyngeal squamous cell carcinomas , 1999, Genes, chromosomes & cancer.

[2]  J. Herman,et al.  DNA hypermethylation in tumorigenesis: epigenetics joins genetics. , 2000, Trends in genetics : TIG.

[3]  Peter A. Jones,et al.  DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene , 1997, Oncogene.

[4]  J. Herman,et al.  Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. , 2000, Cancer research.

[5]  K. Uzawa,et al.  Reduced expression of E-cadherin in oral squamous cell carcinoma: relationship with DNA methylation of 5' CpG island. , 1998, International journal of oncology.

[6]  M. Nagai,et al.  Hypermethylation of the p16 gene in normal oral mucosa of smokers. , 2004, International journal of molecular medicine.

[7]  L. E. McDonald,et al.  A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[8]  A. Riggs,et al.  DNA methylation and gene function. , 1980, Science.

[9]  F. Domann,et al.  Differential DNA methylation of the p16 INK4A/CDKN2A promoter in human oral cancer cells and normal human oral keratinocytes. , 1999, Oral oncology.

[10]  H. Eiberg,et al.  Loss of heterozygosity at 9q33 and hypermethylation of the DBCCR1 gene in oral squamous cell carcinoma , 2004, British Journal of Cancer.

[11]  M. Knowles,et al.  Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33. , 1999, Genomics.

[12]  A. Kaneda,et al.  Decreased fidelity in replicating CpG methylation patterns in cancer cells. , 2005, Cancer research.

[13]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Bartek,et al.  High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. , 1996, Cancer research.

[15]  A. Bird,et al.  DNA methylation and chromatin modification. , 1999, Current opinion in genetics & development.

[16]  K. Lam,et al.  Loss of E‐cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance , 2002, Cancer.

[17]  N. Tsuchida,et al.  Promoter hypermethylation profile of tumor‐associated genes p16, p15, hMLH1, MGMT and E‐cadherin in oral squamous cell carcinoma , 2003, International journal of cancer.

[18]  Myung-Jin Kim,et al.  Inactivation patterns of p16/INK4A in oral squamous cell carcinomas , 2004, Experimental & Molecular Medicine.

[19]  J. Herman,et al.  Advances in Brief Inactivation of the DNA Repair Gene O 6-Methylguanine-DNA Methyltransferase by Promoter Hypermethylation is a Common Event in Primary Human Neoplasia 1 , 1999 .

[20]  D. Saranath,et al.  Concurrent hypermethylation of multiple regulatory genes in chewing tobacco associated oral squamous cell carcinomas and adjacent normal tissues. , 2004, Oral oncology.

[21]  T. Mukai,et al.  A new imprinted gene cloned by a methylation-sensitive genome scanning method. , 1993, Nucleic acids research.

[22]  M. Toyota,et al.  Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  S. Polak‐Charcon,et al.  DAP kinase links the control of apoptosis to metastasis , 1997, Nature.

[24]  J. Herman,et al.  Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. , 1996, Cancer research.

[25]  Chun Xing Li,et al.  Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3 , 2000, Nature Genetics.

[26]  S. Piantadosi,et al.  Poster 7: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization , 1996, Cancer research.

[27]  B. Casto,et al.  Alterations of p 16 INK 4 a and p 14 ARF in Patients with Severe Oral Epithelial Dysplasia 1 , 2002 .

[28]  C. Plass,et al.  Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC) , 2003, Journal of medical genetics.

[29]  Peter A. Jones,et al.  Cellular differentiation, cytidine analogs and DNA methylation , 1980, Cell.

[30]  T. Tsuji,et al.  The E‐cadherin gene is silenced by CpG methylation in human oral squamous cell carcinomas , 2001, International journal of cancer.

[31]  J. Jen,et al.  Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. , 2001, Cancer research.

[32]  S. Shintani,et al.  High frequency of homozygous deletion and methylation of p16(INK4A) gene in oral squamous cell carcinomas. , 2001, Cancer letters.

[33]  K. Bleicher,et al.  Analysis of the FHIT gene and its product in squamous cell carcinomas of the head and neck , 1998, Oncogene.

[34]  K. Münger,et al.  Re-expression of endogenous p16ink4a in oral squamous cell carcinoma lines by 5-aza-2′-deoxycytidine treatment induces a senescence-like state , 1998, Oncogene.

[35]  S. Baylin,et al.  Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon , 1994, Nature Genetics.

[36]  R. Weber,et al.  Differential Methylation Status of Tumor-Associated Genes in Head and Neck Squamous Carcinoma , 2004, Clinical Cancer Research.

[37]  Y. Lo,et al.  Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction. , 1999, Cancer research.

[38]  V. Chapman,et al.  Use of a HpaII-polymerase chain reaction assay to study DNA methylation in the Pgk-1 CpG island of mouse embryos at the time of X-chromosome inactivation , 1990, Molecular and cellular biology.

[39]  A. El‐Naggar,et al.  Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma. , 1997, The American journal of pathology.

[40]  K. Kelsey,et al.  Patterns of gene promoter methylation in squamous cell cancer of the head and neck , 2002, Oncogene.

[41]  M. Knowles,et al.  Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33. , 1998 .

[42]  G. Liang,et al.  Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. , 1997, Cancer research.

[43]  L. Kasturi,et al.  Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Califano,et al.  Intraoperative molecular margin analysis in head and neck cancer. , 2004, Archives of otolaryngology--head & neck surgery.

[45]  A. Cheng,et al.  Multiple molecular alterations of FHIT in betel‐associated oral carcinoma , 2002, The Journal of pathology.

[46]  Y. Hosoya,et al.  Establishment of methylation-sensitive-representational difference analysis and isolation of hypo- and hypermethylated genomic fragments in mouse liver tumors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Jan-Gowth Chang,et al.  The correlation between CpG methylation on promoter and protein expression of E-cadherin in oral squamous cell carcinoma. , 2002, Anticancer research.

[48]  B. Casto,et al.  Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia. , 2002, Cancer research.

[49]  J. Herman,et al.  A gene hypermethylation profile of human cancer. , 2001, Cancer research.

[50]  S. Lippman,et al.  Hypermethylation of the Retinoic Acid Receptor-β2 Gene in Head and Neck Carcinogenesis , 2004, Clinical Cancer Research.

[51]  M. Anzola,et al.  Gene promoter hypermethylation in oral rinses of leukoplakia patients--a diagnostic and/or prognostic tool? , 2003, European journal of cancer.

[52]  Peter A. Jones,et al.  Cancer-epigenetics comes of age , 1999, Nature Genetics.

[53]  D. Lubahn,et al.  Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique. , 1997, Cancer research.

[54]  Y. Kudo,et al.  Invasion and Metastasis of Oral Cancer Cells Require Methylation of E-Cadherin and/or Degradation of Membranous β-Catenin , 2004, Clinical Cancer Research.

[55]  J. Herman,et al.  Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation. , 1999, Cancer research.

[56]  N. Matsubara,et al.  Effects of demethylating agent 5-aza-2(')-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines. , 2004, Oral oncology.